Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/ndt/gfae019 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
SGLT2 Inhibitors: Paradigm Shift from Diabetes Care to Metabolic Care-An Indian Perspective.
Indian J Endocrinol Metab
February 2024
Evidence Generation Centre and Strategic Alliances, Janssen Inc., Ontario, Canada.
The prevalence and burden of diabetes are on the rise in India, making it 'the diabetes capital of the world'. Comorbidities such as obesity, cardiovascular (CV) complications, chronic kidney disease (CKD), non-alcoholic fatty liver disease (NAFLD), and neurodegenerative diseases are common in patients with diabetes. Recent breakthroughs in diabetes medications and continuous glucose monitoring have resulted in a paradigm shift in diabetes care.
View Article and Find Full Text PDFCardio-renoprotective effects of SGLT2 inhibitors-the role of anaemia correction.
Nephrol Dial Transplant
May 2024
Department of Nephrology and Dialysis, Sant'Anna Hospital, ASST Lariana, Como, Italy.
Blood pressure reduction in the morning yields beneficial effects on progression of chronic renal insufficiency with regression of left ventricular hypertrophy.
Clin Exp Hypertens
July 2002
Department of Nephrology, Saitama Medical School, Japan.
Self-monitoring values of blood pressure may better reflect the average long-term blood pressure value than sporadic measurements in the physician's office and be more useful for blood pressure control. In the present study, we compared the results of self-monitoring of blood pressure values, especially in the morning, with office blood pressure, and related these to progression of chronic renal insufficiency and left ventricular hypertrophy (LVH). Thirty-four patients were selected from 316 subjects with chronic renal insufficiency (average serum creatinine 1.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!